News for PAVmed Inc. (PAVM)

PR NewswireNEW YORK, March 4, 2025 NEW YORK, March 4, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-s

PR NewswireNEW YORK, Feb. 27, 2025 Lucid to support study of this expanded indication for esophageal precancer testing in partnership with NIH investigator

PR NewswireNEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-s

PR NewswireNEW YORK, Feb. 24, 2025 Gross proceeds of approximately $2.4 million from sale of PAVmed securities priced at-the-market and Veris common stock

PR NewswireNEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified com

Cutera Inc. (CUTR), a company specializing in medical devices, experienced a notable stock price increase of 5.74%. The stock is currently trading at $0.437 per

PR NewswireNEW YORK, Jan. 13, 2025 Quarterly test volume of over 4,000 tests represented sequential increase of 45 percentNEW YORK, Jan. 13, 2025 /PRNewswi

PR NewswireNEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-s

PR NewswireNEW YORK, Dec. 11, 2024 Study demonstrates outstanding clinical utility including an exceptionally high 85% patient compliance with referral to

PR NewswireNEW YORK, Dec. 3, 2024 New convertible debt financing with existing long-term equity shareholders yields ~$18M in net cash proceeds after paying

PR NewswireNEW YORK, Nov. 20, 2024 NEW YORK, Nov. 20, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-st

PAVmed Inc. (NASDAQ:PAVM) Q3 2024 Earnings Call Transcript November 14, 2024 8:30 AM ETCompany ParticipantsMatt Riley - Director of IRLishan Aklog -...

The following slide deck was published by PAVmed Inc.

PAVmed (PAVM) is set to report Q3 earnings on November 14th.

PAVmed subsidiary receives $1.8 million NIH grant for cancer care

Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024

Cutera Inc (CUTR), a medical device company, experienced a significant stock drop of 5.27%. The current share price stands at $0.710 with a trading volume of 58

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.